These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 8392081)

  • 1. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
    Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R; Faggiano A; Filippella M; Di Somma C; De Martino MC; Gaccione M; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic pituitary adrenal function in the extremely low birth weight infant.
    Hanna CE; Keith LD; Colasurdo MA; Buffkin DC; Laird MR; Mandel SH; Cook DM; LaFranchi SH; Reynolds JW
    J Clin Endocrinol Metab; 1993 Feb; 76(2):384-7. PubMed ID: 8381799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.
    Mortola JF; Rasmussen DD; Yen SS
    J Clin Endocrinol Metab; 1989 Mar; 68(3):517-22. PubMed ID: 2537336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants.
    Ng PC; Lam CW; Lee CH; Ma KC; Fok TF; Chan IH; Wong E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4621-8. PubMed ID: 12364445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to corticotropin-releasing hormone during pregnancy in the baboon.
    Goland RS; Stark RI; Wardlaw SL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):925-9. PubMed ID: 2156891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
    Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids.
    Ng PC; Wong GW; Lam CW; Lee CH; Wong MY; Fok TF; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3548-52. PubMed ID: 9360505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal function in uncomplicated falciparum malaria.
    Wilson M; Davis TM; Binh TQ; Long TT; Danh PT; Robertson K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):689-95. PubMed ID: 12041540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.